Literature DB >> 22762397

Spontaneous regression of hepatocellular carcinoma is most often associated with tumour hypoxia or a systemic inflammatory response.

Jonathan I Huz1, Marcovalerio Melis, Umut Sarpel.   

Abstract

BACKGROUND: Spontaneous regression of hepatocellular carcinoma (HCC) is well documented, although the aetiology of this phenomenon remains unknown.
METHODS: A review of the English literature was performed for reports of spontaneous regression of HCC. Reports were classified by mechanism based on the available information.
RESULTS: Spontaneous regression of HCC has been identified in 75 patients. The most common mechanisms of regression identified were tumour hypoxia (n= 21, 28.0%), a systemic inflammatory response (n= 25, 33.3%) and unknown (n= 29, 38.7%). In patients where tumour hypoxia was described as the aetiology, mechanisms included spontaneous hepatic artery thrombosis and sustained systemic hypotension. In patients where a systemic inflammatory response was the aetiology, mechanisms included cholangitis, trauma and elevated cytokine levels. DISCUSSION: Spontaneous regression of HCC is most commonly associated with tumour hypoxia or a systemic inflammatory response. Determining the aetiology of spontaneous regression may identify potential therapeutic pathways. Tumour hypoxia is already the basis of treatment modalities such as hepatic artery embolization and the anti-angiogenic agent sorafenib. However, treatment modalities for HCC do not currently include immune-directed therapies; this may prove to be a worthy target for future research.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 22762397      PMCID: PMC3406346          DOI: 10.1111/j.1477-2574.2012.00478.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  74 in total

1.  Spontaneous regression of cancer: preliminary report.

Authors:  W H COLE; T C EVERSON
Journal:  Ann Surg       Date:  1956-09       Impact factor: 12.969

2.  Regression of hepatocellular carcinoma.

Authors:  T Mochizuki; Y Takehara; T Nishimura; M Takahashi; M Kaneko
Journal:  AJR Am J Roentgenol       Date:  1991-04       Impact factor: 3.959

3.  Long-term survival with tumor regression in androgen-induced liver tumors.

Authors:  G W McCaughan; M J Bilous; N D Gallagher
Journal:  Cancer       Date:  1985-12-01       Impact factor: 6.860

4.  Spontaneous regression of hepatocellular carcinoma.

Authors:  Shunsuke Kondo; Takuji Okusaka; Hideki Ueno; Masafumi Ikeda; Chigusa Morizane
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

Review 5.  Spontaneous necrosis of hepatocellular carcinoma: a case report.

Authors:  Yoshikazu Morimoto; Yasuhiro Tanaka; Toshinori Itoh; Shigetaka Yamamoto; Hitoshi Mizuno; Hiroaki Fushimi
Journal:  Dig Surg       Date:  2002       Impact factor: 2.588

6.  Necrosis of hepatocellular carcinoma as a result of subintimal injury incurred by hepatic angiography: report of two cases.

Authors:  K Takayasu; Y Muramatsu; Y Shima; N Moriyama; T Yamada; T Yoshida; M Makuuchi; K Kishi
Journal:  Am J Gastroenterol       Date:  1986-10       Impact factor: 10.864

Review 7.  Sorafenib for treatment of hepatocellular carcinoma: a systematic review.

Authors:  Bingru Xie; David H Wang; Stuart Jon Spechler
Journal:  Dig Dis Sci       Date:  2012-03-27       Impact factor: 3.199

Review 8.  Spontaneous regression of hepatocellular carcinoma.

Authors:  M Grossmann; R Hoermann; M Weiss; K W Jauch; H Oertel; A Staebler; K Mann; D Engelhardt
Journal:  Am J Gastroenterol       Date:  1995-09       Impact factor: 10.864

Review 9.  Vanishing liver tumours.

Authors:  P Peddu; D Huang; P A Kane; J B Karani; A S Knisely
Journal:  Clin Radiol       Date:  2007-11-26       Impact factor: 2.350

10.  Necrosis of hepatocellular carcinoma caused by spontaneously arising arterial thrombus.

Authors:  S Imaoka; Y Sasaki; S Masutani; O Ishikawa; H Furukawa; T Kabuto; M Kameyama; S Ishiguro; Y Hasegawa; H Koyama
Journal:  Hepatogastroenterology       Date:  1994-08
View more
  31 in total

Review 1.  The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant.

Authors:  Kobe Reynders; Tim Illidge; Shankar Siva; Joe Y Chang; Dirk De Ruysscher
Journal:  Cancer Treat Rev       Date:  2015-03-28       Impact factor: 12.111

2.  Mediastinal hepatocellular carcinoma with unknown primary: an unusual and rare presentation.

Authors:  Peng Soon Koh; Mastura Md Yusof; Boon Koon Yoong; Pathmanathan Rajadurai
Journal:  J Gastrointest Cancer       Date:  2014-12

3.  Hepatocellular carcinoma and immune therapy, from a clinical perspective; where are we?

Authors:  Susanna V Ulahannan; Austin G Duffy
Journal:  Hepat Oncol       Date:  2016-08-19

Review 4.  Current status and perspectives of immune-based therapies for hepatocellular carcinoma.

Authors:  Maridi Aerts; Daphné Benteyn; Hans Van Vlierberghe; Kris Thielemans; Hendrik Reynaert
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 5.  Immune checkpoint inhibitors for hepatocellular carcinoma.

Authors:  Christopher E Jensen; Arturo Loaiza-Bonilla; Paula A Bonilla-Reyes
Journal:  Hepat Oncol       Date:  2016-06-27

Review 6.  Overdiagnosis: An Understudied Issue in Hepatocellular Carcinoma Surveillance.

Authors:  Nicole E Rich; Neehar D Parikh; Amit G Singal
Journal:  Semin Liver Dis       Date:  2017-12-22       Impact factor: 6.115

7.  A rare case of spontaneous necrosis of primary renal cell carcinoma.

Authors:  Kyosuke Matsuzaki; Ryoichi Imamura; Toshichika Iwanishi; Masahiro Nakagawa; Go Tanigawa; Koichi Tsutahara; Kohki Shimazu; Hiroaki Fushimi; Toyonori Tsuzuki; Seiji Yamaguchi
Journal:  Can Urol Assoc J       Date:  2015 Jan-Feb       Impact factor: 1.862

Review 8.  Immunotherapeutic approaches to hepatocellular carcinoma treatment.

Authors:  Alexander G Miamen; Haidong Dong; Lewis R Roberts
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

9.  Spontaneous regression of a biopsy confirmed hepatocellular carcinoma.

Authors:  Neil Bhardwaj; Mo Li; Timothy Price; Guy J Maddern
Journal:  BMJ Case Rep       Date:  2014-07-21

Review 10.  Trends in the treatment of advanced hepatocellular carcinoma: immune checkpoint blockade immunotherapy and related combination therapies.

Authors:  Huijuan Cheng; Guodong Sun; Hao Chen; Yu Li; Zhijian Han; Yangbing Li; Peng Zhang; Luxi Yang; Yumin Li
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.